Analyst Ratings For NASDAQ:IDRA – Idera Pharmaceuticals (NASDAQ:IDRA)
Today, Robert W. Baird lowered its price target on NASDAQ:IDRA – Idera Pharmaceuticals (NASDAQ:IDRA) to per share.
Some recent analyst ratings include
- 5/10/2018-HC Wainwright Reiterated Rating of Buy.
- 9/12/2017-Piper Jaffray Companies Reiterated Rating of Buy.
- 4/11/2017-Wedbush Reiterated Rating of Outperform.
- 11/29/2016-Cowen Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:IDRA – Idera Pharmaceuticals (NASDAQ:IDRA)
NASDAQ:IDRA – Idera Pharmaceuticals (NASDAQ:IDRA) has insider ownership of 20.48% and institutional ownership of 42.47%.
- On 1/17/2018 Invest Corp Pillar, Major Shareholder, sold 200,000 with an average share price of $2.40 per share and the total transaction amounting to $480,000.00.
- On 12/15/2017 Invest Corp Pillar, Major Shareholder, sold 2,300,000 with an average share price of $1.96 per share and the total transaction amounting to $4,508,000.00.
- On 12/13/2017 Invest Corp Pillar, Major Shareholder, sold 1,100,000 with an average share price of $1.93 per share and the total transaction amounting to $2,123,000.00.
- On 10/26/2017 Bros. Advisors Lp Baker, Director, bought 8,000,000 with an average share price of $1.50 per share and the total transaction amounting to $12,000,000.00.
- On 5/1/2017 Invest Corp Pillar, Director, sold 450,815 with an average share price of $2.26 per share and the total transaction amounting to $1,018,841.90.
- On 4/25/2017 Invest Corp Pillar, Director, sold 1,328,422 with an average share price of $2.29 per share and the total transaction amounting to $3,042,086.38.
- On 4/24/2017 Invest Corp Pillar, Director, sold 437,829 with an average share price of $2.29 per share and the total transaction amounting to $1,002,628.41.
Recent Trading Activity for NASDAQ:IDRA – Idera Pharmaceuticals (NASDAQ:IDRA)
Shares of NASDAQ:IDRA – Idera Pharmaceuticals closed the previous trading session at 1.76 +0.00 0.00% with 1.75 shares trading hands.